Stryker (SYK) Income from Continuing Operations (2009 - 2026)
Stryker's (SYK) quarterly Income from Continuing Operations came in at $1.3 billion in Q2 2026, up 44.34% year-over-year from $884.0 million in Q2 2025, and up 71.28% quarter-over-quarter from $745.0 million in Q1 2026.
Analysis
Stryker (SYK) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Income from Continuing Operations for 18 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income from Continuing Operations rose 44.34% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $3.7 billion, a 27.79% increase from a year earlier, with the FY2025 full-year figure at $3.2 billion, up 8.45% from the prior year.
- Income from Continuing Operations was $1.3 billion for Q2 2026 at Stryker, up from $745.0 million in the prior quarter.
- Over five years, Income from Continuing Operations peaked at $1.3 billion in Q2 2026 and troughed at $323.0 million in Q1 2022.
- A 5-year average of $765.7 million and a median of $766.5 million in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations surged 103.02% in 2023 and sank 52.23% in 2024, its largest moves.
- Over 5 years, Income from Continuing Operations stood at $563.0 million in 2022, then surged by 103.02% to $1.1 billion in 2023, then slumped by 52.23% to $546.0 million in 2024, then jumped by 55.49% to $849.0 million in 2025, then soared by 50.29% to $1.3 billion in 2026.
- The last three Income from Continuing Operations figures came in at $1.3 billion (Q2 2026), $745.0 million (Q1 2026), and $849.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 185.16 Bn | 179.56 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 124.38 Bn | 119.16 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.06 Bn | 101.58 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.75 Bn | 66.21 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.81 Bn | 45.55 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.28 Bn |
| Mar 31, 2026 | 745.00 Mn |
| Dec 31, 2025 | 849.00 Mn |
| Sep 30, 2025 | 859.00 Mn |
| Jun 30, 2025 | 884.00 Mn |
| Mar 31, 2025 | 654.00 Mn |
| Dec 31, 2024 | 546.00 Mn |
| Sep 30, 2024 | 834.00 Mn |
| Jun 30, 2024 | 825.00 Mn |
| Mar 31, 2024 | 788.00 Mn |
| Dec 31, 2023 | 1.14 Bn |
| Sep 30, 2023 | 692.00 Mn |
| Jun 30, 2023 | 738.00 Mn |
| Mar 31, 2023 | 592.00 Mn |
| Dec 31, 2022 | 563.00 Mn |
| Sep 30, 2022 | 816.00 Mn |
| Jun 30, 2022 | 656.00 Mn |
| Mar 31, 2022 | 323.00 Mn |
| Dec 31, 2021 | 662.00 Mn |
| Sep 30, 2021 | 438.00 Mn |